Results 201 to 210 of about 14,786 (290)

PROTACs for Collateral Degradation: Is It Time to Back Up the Bus? [PDF]

ACS Med Chem Lett
Gao ZG, Burgess K.
europepmc   +1 more source

Extracellular Vesicle-Mediated Nucleolin Transfer in Glioblastoma: A Targetable Axis Driving Blood-Tumour Barrier Formation. [PDF]

J Extracell Vesicles
Chen H, Zhao J, Qiu F, Wang Z, Li J, Zhang L, Lu A, Liang C.   +7 more
europepmc   +1 more source

Development of PROTACs for targeted degradation of oncogenic TRK fusions. [PDF]

RSC Chem Biol
Kumar S, Jiang J, Donald-Paladino MS, Chen J, Gutierrez A, Federation AJ, Szulzewsky F, Holland EC, Ferguson FM, Nabet B.   +9 more
europepmc   +1 more source

Unveiling BCL-xL-specific PROTAC efficiency and dissociation pathways using native mass spectrometry. [PDF]

Chem Sci
Gadallah MI, Nonhof KL, Nayak D, Zhang P, Dioli O, Zheng G, Olsen SK, Zhou D, Brodbelt JS.   +8 more
europepmc   +1 more source

Unlocking the therapeutic potential of HDAC8-degrading PROTACs: progress, challenges, and future directions. [PDF]

RSC Med Chem
Banerjee S, Adhikari N, Ghosh B.
europepmc   +1 more source

Prospects and advances of PROTAC in the treatment of hematologic malignancies. [PDF]

Exp Hematol Oncol
Wang X, Zhang M, Mei H.
europepmc   +1 more source

Induced-proximity therapeutics for targeted protein and RNA degradation: An organic chemistry Perspective-A review. [PDF]

Curr Res Struct Biol
Rizehbandi M, Dadfar E, Rezaei Nami M, Rezaei Nami M, Rezaei Nami M.   +4 more
europepmc   +1 more source

The ubiquitin system, disease, and drug discovery [PDF]

core   +1 more source

Discovery of SKP2-Recruiting PROTACs for Target Protein Degradation. [PDF]

Adv Sci (Weinh)
Dong G, Huang A, Zhao Z, Lai B, Pan X, Yang H, Xu X, Wang T, Zhao F, Zhang Z, Xue Y, Deng G, Deng W, Chen J.   +13 more
europepmc   +1 more source

Editorial: The ubiquitin-proteasome system and cellular signaling: mechanisms and regulatory roles in cancer and infectious diseases. [PDF]

Front Cell Dev Biol
Islam S, Hussain A, Alam A, Ansari MO, Saeed H, Khan S.   +5 more
europepmc   +1 more source